<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The present study aimed at understanding the effect of the <z:chebi fb="0" ids="17351">linoleic acid</z:chebi> derivative 8-[2-(2-<z:chebi fb="0" ids="25902">pentyl</z:chebi>-cyclopropylmethyl)-<z:chebi fb="0" ids="30364">cyclopropyl</z:chebi>]-<z:chebi fb="0" ids="28837">octanoic acid</z:chebi> (DCP-LA) on <z:mp ids='MP_0003674'>oxidative stress</z:mp>-induced neuronal <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="0" ids="29321">Sodium nitroprusside</z:chebi> (SNP; 1 mM) <z:mp ids='MP_0010831'>reduced viability</z:mp> of cultured rat cerebral cortical neurons to 50% of basal levels, but DCP-LA significantly prevented the SNP effect in a concentration (1-100 nM)-dependent manner </plain></SENT>
<SENT sid="2" pm="."><plain>In addition, DCP-LA (100 nM) rescued neurons from SNP-induced degradation </plain></SENT>
<SENT sid="3" pm="."><plain>SNP (1 mM) activated caspase-3 and -9 in cultured rat cerebral cortical neurons, but DCP-LA (100 nM) abolished the caspase activation </plain></SENT>
<SENT sid="4" pm="."><plain>For a mouse model of middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp>, oral administration with DCP-LA (1 mg/kg) significantly diminished degraded area due to <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The results of the present study, thus, demonstrate that DCP-LA protects neurons at least in part from <z:mp ids='MP_0003674'>oxidative stress</z:mp>-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> by inhibiting activation of caspase-3/-9 </plain></SENT>
</text></document>